ATOORO Fund is an Israeli family venture fund that aims to support innovative entrepreneurs in building global companies. They focus on deep-technology ventures across several high-growth areas, including AI Models & Inference Computing, Physical AI & Robotics, Food Security, Bio-Mathematics, Quantum Computing, Computational Biology, and Clinical and Health Systems Platforms. The fund targets early and seed stages, providing initial investments typically ranging from $0.5 million to $5 million. They prefer to lead or co-lead the investment rounds they participate in, indicating an active role in guiding and supporting their portfolio companies. ATOORO's strategy involves identifying and investing in companies that are developing cutting-edge technologies within their focus areas. This includes companies involved in bioinformatics, food security (such as autonomous beehives and novel farming systems), quantum computing (quantum search and simulation), space commercialization (nanosatellites and space data services), synthetic biology (cellular agriculture and bioprinted organs), and perceptual computing (real-time 3D scanning and human-computer interaction). The diversity of these sectors demonstrates a broad interest in disruptive technologies. The fund's investment approach reflects a commitment to supporting early-stage companies with significant growth potential. By leading or co-leading rounds, ATOORO likely aims to take a more active role in providing strategic guidance, mentorship, and access to their network. As a family venture fund, it may also offer a long-term perspective and patient capital to nurture its investments over time. Overall, ATOORO's strategy revolves around identifying promising deep-tech ventures in Israel and globally, providing them with early-stage funding, and actively supporting their growth through strategic guidance and access to resources. Their focus on specific technology verticals and their preference for leading or co-leading rounds highlight their commitment to actively participating in the success of their portfolio companies.
Bevorzugte Reifephase für die erste Finanzierung.
AI Models & Inference Computing, Physical AI & Robotics, Food Security, Bio-Mathematics, Quantum Computing, Computational Biology, Clinical and Health Systems Platforms, Bioinformatics, Space Commercialization, Synthetic Biology, Perceptual Computing
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
